PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Parnaparin→

Parnaparin PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
9041-08-1
Molecular formula
Not available
Molecular weight
Not available
Drug class
Low-molecular-weight heparin (LMWH)anticoagulant and antithrombotic
Mechanism of action
Binds antithrombin and accelerates inhibition of activated coagulation factor Xa, with a lower inhibitory effect on thrombin (factor IIa). Its anti-Xa activity exceeds its anti-IIa activity, as expected for this LMWH.
Indications / reported uses
  • Prevention and treatment of venous thromboembolic disorders in clinical settings covered by the locally authorised parnaparin product information; exact indication and dosing depend on formulation and jurisdiction.

Sources: https://registrasiobat.pom.go.id/files/assesment-reports/obat_baru/Fluxum.pdf · https://meshb.nlm.nih.gov/record/ui?name=parnaparin · https://www.mhlw.go.jp/content/11120000/000904449.pdf

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Parnaparin PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Parnaparin Permitted Daily Exposure (PDE) report (the Parnaparin PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Parnaparin Occupational Exposure Limit (OEL) report (the Parnaparin OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.